These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 25341111)

  • 101. Molecular mechanisms and differences in lynch syndrome developing into colorectal cancer and endometrial cancer based on gene expression, methylation, and mutation analysis.
    Li H; Sun L; Zhuang Y; Tian C; Yan F; Zhang Z; Hu Y; Liu P
    Cancer Causes Control; 2022 Apr; 33(4):489-501. PubMed ID: 35149954
    [TBL] [Abstract][Full Text] [Related]  

  • 102. DNA Mismatch Repair-deficient Rectal Cancer Is Frequently Associated With Lynch Syndrome and With Poor Response to Neoadjuvant Therapy.
    Farchoukh LF; Celebrezze J; Medich D; Cunningham K; Holder-Murray J; Holtzman M; Lee K; Choudry H; Pai RK
    Am J Surg Pathol; 2022 Sep; 46(9):1260-1268. PubMed ID: 35551135
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Response to first line platinum-based chemotherapy in mismatch repair deficient (MMRd)/ microsatellite instability high (MSI-high) endometrial carcinoma.
    Colomba E; Alexandre J; Le Teuff G; Genestie C; Coupez D; Coquard IR; Brachet PE; de Percin S; Sajous C; Fabbro M; Delanoy N; Joly F; Frenel JS; Pautier P; Leary A
    Gynecol Oncol; 2023 Feb; 169():78-84. PubMed ID: 36521352
    [TBL] [Abstract][Full Text] [Related]  

  • 104. GREM1 germline mutation screening in Ashkenazi Jewish patients with familial colorectal cancer.
    Laitman Y; Jaeger E; Katz L; Tomlinson I; Friedman E
    Genet Res (Camb); 2015 May; 97():e11. PubMed ID: 25992589
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Prevalence and predictors of appropriate colorectal cancer surveillance in Lynch syndrome.
    Stoffel EM; Mercado RC; Kohlmann W; Ford B; Grover S; Conrad P; Blanco A; Shannon KM; Powell M; Chung DC; Terdiman J; Gruber SB; Syngal S
    Am J Gastroenterol; 2010 Aug; 105(8):1851-60. PubMed ID: 20354509
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Immunogenomic Biomarkers and Validation in Lynch Syndrome.
    Chambuso R; Mthembu M; Kaambo E; Robertson B; Ramesar R
    Cells; 2023 Feb; 12(3):. PubMed ID: 36766832
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Province-Wide Ascertainment of Lynch Syndrome in Manitoba.
    Rothenmund H; Lambert P; Khan D; Kim C; Sharma B; Serfas K; Chodirker B; Singh H
    Clin Gastroenterol Hepatol; 2024 Mar; 22(3):642-652.e2. PubMed ID: 37879520
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Phase II Study of Avelumab in Patients With Mismatch Repair Deficient and Mismatch Repair Proficient Recurrent/Persistent Endometrial Cancer.
    Konstantinopoulos PA; Luo W; Liu JF; Gulhan DC; Krasner C; Ishizuka JJ; Gockley AA; Buss M; Growdon WB; Crowe H; Campos S; Lindeman NI; Hill S; Stover E; Schumer S; Wright AA; Curtis J; Quinn R; Whalen C; Gray KP; Penson RT; Cannistra SA; Fleming GF; Matulonis UA
    J Clin Oncol; 2019 Oct; 37(30):2786-2794. PubMed ID: 31461377
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Prevalence and Genotype-Phenotype Correlation of Lynch Syndrome in a Selected High-Risk Cohort from Qatar's Population.
    Sidenna M; Khodjet-El-Khil H; Al Mulla H; Al-Shafai M; Habish HH; Al-Sulaiman R; Al-Bader SB
    Genes (Basel); 2022 Nov; 13(11):. PubMed ID: 36421850
    [TBL] [Abstract][Full Text] [Related]  

  • 110. Which Lynch syndrome screening programs could be implemented in the "real world"? A systematic review of economic evaluations.
    Di Marco M; DAndrea E; Panic N; Baccolini V; Migliara G; Marzuillo C; De Vito C; Pastorino R; Boccia S; Villari P
    Genet Med; 2018 Oct; 20(10):1131-1144. PubMed ID: 29300371
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Delineating genotype and parent-of-origin effect on the phenotype in MSH6-associated Lynch syndrome.
    van der Werf-'t Lam AS; Rodriguez-Girondo M; Villasmil M; Tops CM; van Hest L; Gille HJP; Duijkers FAM; Wagner A; Eikenboom E; Letteboer TGW; de Jong MM; Bajwa-Ten Broeke SW; Bleeker F; Gomez Garcia EB; Dominguez-Valentin M; Møller P; Suerink M; Nielsen M
    Genes Chromosomes Cancer; 2024 May; 63(5):e23237. PubMed ID: 38722212
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Gut microbial signatures are associated with Lynch syndrome (LS) and cancer history in Druze communities in Israel.
    Naddaf R; Carasso S; Reznick-Levi G; Hasnis E; Qarawani A; Maza I; Gefen T; Half EE; Geva-Zatorsky N
    Sci Rep; 2023 Nov; 13(1):20677. PubMed ID: 38001152
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Performance of PREMM(1,2,6), MMRpredict, and MMRpro in detecting Lynch syndrome among endometrial cancer cases.
    Mercado RC; Hampel H; Kastrinos F; Steyerberg E; Balmana J; Stoffel E; Cohn DE; Backes FJ; Hopper JL; Jenkins MA; Lindor NM; Casey G; Haile R; Madhavan S; de la Chapelle A; Syngal S;
    Genet Med; 2012 Jul; 14(7):670-80. PubMed ID: 22402756
    [TBL] [Abstract][Full Text] [Related]  

  • 114. Distinct Mechanisms of Mismatch-Repair Deficiency Delineate Two Modes of Response to Anti-PD-1 Immunotherapy in Endometrial Carcinoma.
    Chow RD; Michaels T; Bellone S; Hartwich TMP; Bonazzoli E; Iwasaki A; Song E; Santin AD
    Cancer Discov; 2023 Feb; 13(2):312-331. PubMed ID: 36301137
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Mismatch Repair (MMR) Gene Mutation Carriers Have Favorable Outcome in Colorectal and Endometrial Cancer: A Prospective Cohort Study.
    Yeh JT; Peng HP; Hung FH; Hung CF; Hsieh LL; Yang AS; Wang YA
    Cancers (Basel); 2024 Jun; 16(13):. PubMed ID: 39001404
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Gut Microbiome Composition in Lynch Syndrome With and Without History of Colorectal Neoplasia and Non-Lynch Controls.
    Rifkin SB; Sze MA; Tuck K; Koeppe E; Stoffel EM; Schloss PD
    J Gastrointest Cancer; 2024 Mar; 55(1):207-218. PubMed ID: 37310549
    [TBL] [Abstract][Full Text] [Related]  

  • 117. Endometrial cancer risk factors among Lynch syndrome women: a retrospective cohort study.
    Staff S; Aaltonen M; Huhtala H; Pylvänäinen K; Mecklin JP; Mäenpää J
    Br J Cancer; 2016 Jul; 115(3):375-81. PubMed ID: 27336600
    [TBL] [Abstract][Full Text] [Related]  

  • 118. Adaptation and early implementation of the PREdiction model for gene mutations (PREMM
    Mittendorf KF; Ukaegbu C; Gilmore MJ; Lindberg NM; Kauffman TL; Eubanks DJ; Shuster E; Allen J; McMullen C; Feigelson HS; Anderson KP; Leo MC; Hunter JE; Sasaki SO; Zepp JM; Syngal S; Wilfond BS; Goddard KAB
    Fam Cancer; 2022 Apr; 21(2):167-180. PubMed ID: 33754278
    [TBL] [Abstract][Full Text] [Related]  

  • 119. Direct-to-patient disclosure of results of mismatch repair screening for Lynch syndrome via electronic personal health record: a feasibility study.
    Hall MJ; Herda MM; Handorf EA; Rybak CC; Keleher CA; Siemon M; Daly MB
    Genet Med; 2014 Nov; 16(11):854-61. PubMed ID: 24784156
    [TBL] [Abstract][Full Text] [Related]  

  • 120. Practice patterns and results of tumor and germline genetic evaluation of women with endometrial cancer in south Louisiana.
    McDougal M; Nair-Fairless P; Weiss T; Dao E; Chapple AG; Jernigan A
    Gynecol Oncol Rep; 2021 May; 36():100717. PubMed ID: 33598523
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.